NMPA Approval

Metformin Hydrochloride and Empagliflozin Tablets（Ⅲ）

Approval Number

国药准字H20253034

Company成都蜀西制药有限公司

Registration Date

January 2, 2025

Drug Information

Generic Name

二甲双胍恩格列净片(Ⅲ)

Dosage Form

片剂

Strength

每片含盐酸二甲双胍850mg与恩格列净5mg

Drug Type

化学药品

Registration Date

January 2, 2025

Company Information

Applicant Company

Company Name成都蜀西制药有限公司

Company Address

成都市蒲江县工业集中发展区工业北路225号

Manufacturing Company

Company Name成都蜀西制药有限公司

Company Address

成都市蒲江县工业集中发展区工业北路225号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

二甲双胍恩格列净片(Ⅲ) - NMPA 批准文号 | MedPath